Sign in to your account
or
By signing in you agree to our
Terms & conditions
 and 
Privacy policy
Sku Image
Sku Image
sold out tag

Gefimipsa 250mg Capsule

Gefitinib (250mg)
Genuine
Authenticity Assured
Prescription
required
Gefimipsa 250mg Capsule is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.

Written By Dr. Subita Alagh, BDS,
Reviewed By Dr. Sachin Gupta, MD Pharmacology, MBBS,
Last updated on 11 Feb 2026 | 05:31 PM (IST)
₹1272 MRP ₹1396.889% off 
 
 
0
footer-icon
sales banner

Save more with additional offers

offer icon
10% cashback up to 200 on Min Transaction of Rs.1000, for first time users of Airtel Payments Bank.
10% cashback up to 200 on Min Transaction of Rs.1000, for first time users of Airtel Payments Bank.
chevron icon
offer icon
Pay with Amazon Pay Balance and get cashback up to Rs. 75 with minimum cashback of Rs. 15
Pay with Amazon Pay Balance and get cashback up to Rs. 75 with minimum cashback of Rs. 15
chevron icon
offer icon
Earn cashback up to Rs.75 with Amazon Pay Later
Earn cashback up to Rs.75 with Amazon Pay Later
chevron icon
offer icon
10% cashback up to 200 on Min Transaction of Rs.1000, for first time users of Airtel Payments Bank.
10% cashback up to 200 on Min Transaction of Rs.1000, for first time users of Airtel Payments Bank.
chevron icon
offer icon
Pay with Amazon Pay Balance and get cashback up to Rs. 75 with minimum cashback of Rs. 15
Pay with Amazon Pay Balance and get cashback up to Rs. 75 with minimum cashback of Rs. 15
chevron icon
offer icon
Earn cashback up to Rs.75 with Amazon Pay Later
Earn cashback up to Rs.75 with Amazon Pay Later
chevron icon
offer icon
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
chevron icon
offer icon
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI.
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI.
chevron icon
offer icon
Assured cashback up to ₹300 on minimum payment of ₹300 using Paytm UPI*
Assured cashback up to ₹300 on minimum payment of ₹300 using Paytm UPI*
chevron icon

General Information

The content is shown in English
Gefimipsa 250mg Capsule image
Gefimipsa 250mg Capsule image

Product introduction

Gefimipsa 250mg Capsule should be taken in a dose as recommended by the doctor. You should continue to take it as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. Your doctor may advice for regular monitoring of liver function while your taking this medicine.


Common side effects include diarrhea, dry skin, loss of appetite, and nausea. Drink plenty of fluids to reduce the risk of side effects. Inform your doctor if any of the side effects bother you or get worse. In case you develop ulceration in mouth, changes in your vision, or breathing difficulties than it is better to inform the doctor.


Women who are undergoing treatment should use effective contraception method. It is important to avoid pregnancy during the treatment and for a month after completing the course of medicine. Let your doctor also know about all the other medications you are taking.

Uses of Gefimipsa Capsule

Benefits of Gefimipsa Capsule

Non-small cell lung cancer
Non-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers. Gefimipsa 250mg Capsule helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.

Side effects of Gefimipsa Capsule

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Gefimipsa
  • Diarrhea
  • Dry skin
  • Loss of appetite
  • Nausea
  • Rash
  • Vomiting
  • Weakness
  • Allergic reaction

How to use Gefimipsa Capsule

Take this medicine in the dose and duration as advised by your doctor. Gefimipsa 250mg Capsule may be taken with or without food.

How Gefimipsa Capsule works

Gefimipsa 250mg Capsule is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

Quick tips

  • Gefimipsa 250mg Capsule helps treat non-small cell lung cancer that is locally advanced, or has spread to other areas of the body.
  • Take it with or without food, preferably at the same time each day.
  • Do not take antacids (to reduce the acid level of your stomach) 2 hours before or 1 hour after taking this medicine.
  • Diarrhea may occur as a side effect. Drink plenty of fluids and inform your doctor if it doesn't stop or if you find blood in your stools.
  • Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for a month after you stop taking it.
  • Inform your doctor if you develop ulceration in your mouth, changes in your vision or if you experience a worsening cough, shortness of breath, or breathing difficulties while taking this medicine.
  • Your doctor may want you to have regular blood tests to monitor your liver function while you are having treatment with this medicine.

Safety advice

Alcohol

Alcohol

CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Gefimipsa 250mg Capsule. Please consult your doctor.
Pregnancy

Pregnancy

CONSULT YOUR DOCTOR
Gefimipsa 250mg Capsule is not recommended during pregnancy as there is positive evidence of fetal risk based on animal studies. However, it may still be prescribed by a doctor in situations where the benefits outweigh the risks.
Breast feeding

Breast feeding

CAUTION
Gefimipsa 250mg Capsule should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from the body.
Driving

Driving

SAFE
Gefimipsa 250mg Capsule does not usually affect your ability to drive.
Kidney

Kidney

CAUTION
Gefimipsa 250mg Capsule should be used with caution in patients with kidney disease. Dose adjustment may be needed.
Liver

Liver

CAUTION
Gefimipsa 250mg Capsule should be used with caution in patients with severe liver disease. Dose adjustment may be needed.

Interaction with drugs

Taking Gefimipsa with any of the following medicines can modify the effect of either of them and cause some undesirable side effects
Life-threatening

Vinorelbine (Injection Route)

Do not consume Gefitinib with Vinorelbine.
Severe

Vinblastine (Injection Route)

Concomitant use is not recommended. Please consult with your doctor. Gefitinib may raise blood levels of Vinblastine.
Severe

Vincristine (Injection Route)

Concomitant use is not recommended. Please consult with your doctor. Gefitinib may raise blood levels of Vincristine.
Moderate

Paroxetine (Oral Route)

Watch out for symptoms of Gefitinib side effects such as diarrhea, dry eye, vomiting, breathing problems, decreased appetite or rash and consult your doctor if you experience them. Paroxetine may raise blood levels of Gefitinib.
Moderate

Aprepitant (Oral Route)

Watch out for symptoms of Aprepitant side effects such as diarrhea, dry eye, vomiting, breathing problems, decreased appetite or rash and consult your doctor if you experience them. Aprepitant may raise blood levels of Gefitinib.

Frequently asked questions

Gefimipsa 250mg Capsule is a prescription medicine used to treat a type of lung cancer called non-small cell lung cancer (NSCLC) that has specific changes in the EGFR gene. It is typically used in people whose cancer has spread and who haven’t received chemotherapy yet.
Gefimipsa 250mg Capsule is recommended for adults with advanced NSCLC that tests positive for certain EGFR mutations. Your doctor will perform a special test before starting Gefimipsa 250mg Capsule treatment to confirm if this medicine is suitable for you.
Gefimipsa 250mg Capsule may rarely cause serious side effects, including lung inflammation (interstitial lung disease), liver damage, severe diarrhea, or eye problems. Seek medical help immediately if you experience breathing difficulty, eye pain, yellowing of the skin or eyes, or dark urine.
While taking Gefimipsa 250mg Capsule, you should get regular liver function tests and chest scans, avoid prolonged sun exposure due to skin sensitivity, and report any vision changes or breathing difficulties right away.
You should take Gefimipsa 250mg Capsule for as long as your doctor recommends. Treatment may continue until your cancer progresses or side effects become unmanageable. Regular follow-up tests advised by your doctor will help guide this decision.

Fact Box

Chemical Class

Quinazolinamines

Habit Forming

No

Therapeutic Class

ANTI NEOPLASTICS

Action Class

Tyrosine Kinase Inhibitors (TKIs)

References

  1. Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1734-35.
  2. Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 954-55.
  3. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 616-17.
  4. Gefitinib. Luton, Bedfordshire: AstraZeneca UK Limited; 2009 [revised 23 Apr. 2018]. [Accessed 232 Jan. 2019] (online) Available from:
  5. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Gefitinib. [Updated 2018 Dec 3]. [Accessed 18 Feb. 2020] (online) Available from:
  6. Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:
  7. CiplaMed. Gefitinib [Prescribing Information]. [Accessed 06 Apr. 2024] (online) Available from:
  8. Gefitinib. Cheshire, United Kingdom: AstraZeneca UK Ltd.; [Accessed 11 Feb. 2026] (online). Available from:
  9. Gefitinib. Weston, Florida: Apotex Corp.; 2024 [Accessed 11 Feb. 2026] (online). Available from:
Related products
Products related to Gefimipsa 250mg Capsule
100% genuine products
100% genuine products
Safe & secure payments
Safe & secure payments
No contact delivery
No contact delivery
Fully sanitized facilities
Fully sanitized facilities

User feedback

Once A Day
94%
Twice A Day
6%
Others
40%
Non-small cell lung cancer
40%
Small cell lung cancer
20%
Poor
44%
Average
33%
Excellent
22%
No Side Effect
67%
Nausea
33%
With food
50%
With or without food
50%
Average
50%
Expensive
50%
<h3 class=titleMediumExtraBold>Want to know more</h3>

Want to know more

We provide you with authentic, trustworthy and relevant information
<h3 class=titleMediumExtraBold>Have issue with the content</h3>

Have issue with the content

Disclaimer

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

Marketer details

Name: Ark Life Sciences Pvt Ltd
Address: # 50/1 & 2-IIIrd Floor,Yusuf Sarai, New Delhi -110016 (India)

Vendor Details

Country of origin: India
Why we need a prescription?
close sheet